A Before-After Study investigating the effect of an intervention aiming to increase vaccination rates for Hepatitis B, Streptococcus pneumoniae and Herpes Zoster of oncological Patients under Treatment - The Easy Vaccination in Oncology (EVO) Study
Not Applicable
- Conditions
- C80D90Malignant neoplasm, without specification of site
- Registration Number
- DRKS00020118
- Lead Sponsor
- Vivantes Klinikum Neukölln - Hämatologie, Onkologie und Palliativmedizin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 519
Inclusion Criteria
Written informed consent
- Age >/= 18 years
- Established cancer diagnosis
- Baseline: Under anti-neoplastic treatment
- Follow-up: Under anti-neoplastic treatment with at least one doctor appointment at study side at least 4 weeks before
- Intervention: Planned or under anti-neoplastic treatment
Exclusion Criteria
- Patients who are unable to consent
- Known intolerance towards planned vaccinations
- B- and T-cell depleting treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary objective of this trial is to assess the effectiveness of implementing the EVO card in the workflow of hematological-oncological outpatient clinics in increasing vaccination rates for Streptococcus pneumoniae in patients under antineoplastic treatment.
- Secondary Outcome Measures
Name Time Method The secondary objectives are - evaluation of the effectiveness of implementing the EVO card in the workflow of haematological-oncological outpatient clinics and associated increasing vaccination rates für Hepatitis B, Herpes Zoster and Influenza in patients under antineoplastic treatment - Pre-interventional vaccination rates - analyzation of the effectiveness of vaccination in relation to time and sort of antineoplastic treatment and underlying illness - vaccination tolerances - acceptance of the EVO-card by the medical staff